Ongoing efforts by CareKinesis to improve medication safety include iteration of our medication risk mitigation system in EireneRx. Soon, the risk of medication-related arrhythmias will be added to our safety systems, alerting PACE clinicians of participant use of one or more medications that carry the risk of fatal arrhythmia. Driving this effort is Tabula Rasa HealthCare's new Chief Scientific Officer, Jacques Turgeon, BPharm, PhD, who is internationally recognized for his work on the drug metabolism and drug-drug interaction mechanisms.
|